Schering Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCHERING, and what generic and branded alternatives to SCHERING drugs are available?
SCHERING has one hundred and one approved drugs.
Drugs and US Patents for Schering
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | DIPROLENE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 019408-001 | Jan 31, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | METI-DERM | prednisolone | CREAM;TOPICAL | 010209-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | ETRAFON-A | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 014713-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | TINDAL | acetophenazine maleate | TABLET;ORAL | 012254-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-004 | Apr 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Schering
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-001 | Apr 6, 1987 | 4,012,444 | ⤷ Try a Trial |
Schering | DIPROLENE | betamethasone dipropionate | GEL, AUGMENTED;TOPICAL | 019408-002 | Nov 22, 1991 | 4,489,070 | ⤷ Try a Trial |
Schering | PROVENTIL | albuterol sulfate | SOLUTION;INHALATION | 019243-002 | Jan 14, 1987 | 3,644,353 | ⤷ Try a Trial |
Schering Plough | LOTRIMIN | clotrimazole | SOLUTION;TOPICAL | 017613-001 | Approved Prior to Jan 1, 1982 | 3,705,172 | ⤷ Try a Trial |
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-002 | Apr 6, 1987 | 4,012,444 | ⤷ Try a Trial |
Schering | NORMODYNE | labetalol hydrochloride | TABLET;ORAL | 018687-001 | Aug 31, 1987 | 4,012,444 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SCHERING drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 100 mg | ➤ Subscribe | 2014-06-16 |
➤ Subscribe | Oral Suspension | 40 mg/mL | ➤ Subscribe | 2011-02-28 |
➤ Subscribe | Injection | 18 mg/mL, 16.7 mL vials | ➤ Subscribe | 2015-11-24 |
Similar Applicant Names
Here is a list of applicants with similar names.